A method for preparing the natural product Folicanthine, a dicyclic tryptophan indole alkaloid.
By using an inexpensive metal cuprous iodide catalyst and simplifying the synthesis steps, the high cost and complexity of preparing dicyclic tryptamine indole alkaloids in existing technologies have been solved, realizing an efficient and environmentally friendly preparation method. The product, Folicanthine, is suitable for the development of anticancer drugs.
Patent Information
- Application Number
- CN202611265399.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-20
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies for preparing dicyclic tryptamine indole alkaloids suffer from problems such as expensive catalysts, cumbersome procedures, and environmental pollution, making it difficult to achieve efficient and convenient large-scale preparation.
Using inexpensive cuprous iodide as a catalyst and elemental iodine as an oxidant, the natural product Folicanthine, a dicyclic tryptamine indole alkaloid, was prepared through a series of simplified synthetic steps, including the reduction, alkylation, degassing, and oxidation of chiral sulfinimide compounds. The product was then purified to obtain a high-purity product.
The preparation of dicyclic tryptophan indole alkaloids with low energy consumption, low pollution, and high yield has been achieved, which is suitable for laboratory and industrial production. The product has significant anticancer activity.
Smart Images

Figure CN123106718A_ABST
Abstract
Description
Technical Field
[0001] This invention patent belongs to the field of organic synthesis technology, specifically relating to a method for preparing the natural product Folicanthine, a dicyclic tryptophan indole alkaloid. Background Technology
[0002] *Chimonanthus praecox*, belonging to the genus *Chimonanthus* of the family Calycanthaceae, is a second-class protected rare plant in China. Its leaves are primarily used medicinally, and it has various names such as "Fragrant Breeze Tea," "Golden Tea," "Cooling Tea," and "Hairy Mountain Tea." Wild *Chimonanthus praecox* is mainly distributed in the mountainous areas of Dexing and Wuyuan in Jiangxi Province, and has a medicinal history of over a thousand years. In modern medicine, *Chimonanthus praecox* is widely considered a high-quality traditional Chinese medicine raw material for the prevention and treatment of upper respiratory tract infections. It is widely used in the prevention and treatment of colds and influenza, showing significant antibacterial, anti-inflammatory, and antiviral effects. For example, (-)-Folicanthine, a dicyclic tryptophan indole alkaloid found in the fruit of *Chimonanthus praecox*, exhibits cytotoxicity against cancer cells and can be used in cancer-related research, such as studies on gastric and liver cancer.
[0003] In recent years, dicyclic tryptophan indole alkaloids have gained significant importance in the biomedical and pharmaceutical fields due to their diverse structures, rich bioactivity, and high drug yield. They have consistently attracted widespread attention from synthetic chemists and pharmacologists, and their synthesis remains a research hotspot and challenge in the field of organic chemistry synthesis. Dicyclic tryptophan alkaloids are important members of the indole alkaloid family, derived from the oxidative dimerization reaction of tryptophan and tryptophan derivatives. They are composed of hexahydropyrrolo[2,3-b]indole (HPI) structural units linked by easily broken C3a-C3a' σ bonds. Due to the unique structure and important bioactivity of dicyclic tryptophan indole alkaloids, developing novel and efficient synthetic routes and methods for their synthesis is particularly important and has always been a hot topic in organic synthetic chemistry, with significant implications for drug development. Summary of the Invention
[0004] The purpose of this invention is to provide a method for preparing the natural product folicanthine, a dimeric cyclic tryptophan indole alkaloid. The disclosed method uses only inexpensive cuprous iodide as a catalyst and elemental iodine as the dimerizing oxidant, resulting in less environmental pollution, fewer reaction steps, and higher yield. This method avoids the multi-step operations and expensive transition metal catalysts required in traditional synthesis. The starting materials are readily available or commercially accessible, and the reaction operation is simple, making it suitable for laboratory-scale scaling up and industrial production exploration.
[0005] To achieve the above objectives, the present invention provides the following technical solution: a method for preparing the natural product Folicanthine, a dicyclic tryptophan indole alkaloid, comprising the following steps: S1. The chiral sulfinimide compound was dissolved in anhydrous methanol, and then reduced by a reducing agent under ice-water bath conditions. After purification, the chiral sulfinamide compound was obtained. More preferably, sodium borohydride is used as the reducing agent in S1.
[0006] S2. The chiral sulfinamide compound was dissolved in anhydrous tetrahydrofuran solvent, and then alkylating agent and sodium hydride were added under ice-water bath and reacted for 10 hours. After purification, methyl-protected chiral sulfinamide compound was obtained. More preferably, the alkylating agent in S2 is iodomethane.
[0007] S3. The methyl-protected chiral sulfinamide compound was dissolved in anhydrous toluene solvent, and then cuprous iodide and bis(trimethylsilylamine) lithium were added. The mixture was degassed three times under high-purity inert gas protection and then heated for 5 hours. Then, under ice-water bath, an oxidant was added and the reaction was continued for 2 hours. After purification, a dimerized indole compound containing an aryl chiral quaternary carbon center was obtained. In a further preferred embodiment, cuprous iodide is used as the catalyst for the reaction in S3, lithium bis(trimethylsilylamine) is used as the base required for the reaction, nitrogen is used as the high-purity inert gas, the heating temperature is 80 degrees Celsius, and iodine is used as the oxidant.
[0008] S4. The dimeric indole compound containing an aryl chiral quaternary carbon center is dissolved in anhydrous methanol solvent, and then dilute hydrochloric acid solution is added and reacted for 5 hours. After reaction treatment, a diamino dimeric indole compound is obtained. Then, it is further reduced with a reducing agent and purified to obtain the natural product Folicanthine, a dimeric cyclotryptamine indole alkaloid.
[0009] More preferably, the concentration of dilute hydrochloric acid used in S4 is 2 mmol / mL, and the reducing agent is diisobutylaluminum hydrogen.
[0010] Based on the above technical solution, the purification method included in S1~S4 is as follows: the crude product initially obtained in each step is concentrated, then purified by chromatography, and finally a compound with high purity is obtained.
[0011] Based on the above technical solution, the present invention also provides the application of the natural product folicanthine, a dicyclic tryptophan indole alkaloid, in the preparation of drugs for treating cancer.
[0012] The beneficial technical effects of the present invention are as follows: 1. The preparation method provided by this invention has mild reaction conditions, uses inexpensive metal cuprous iodide as a catalyst, has low energy consumption, is environmentally friendly, and is conducive to the large-scale preparation of the natural product folicanthine and its analogues, which are dicyclic tryptamine indole alkaloids.
[0013] 2. The preparation method provided by the present invention has good atom economy and high product yield.
[0014] 3. The preparation method provided by this invention has a shorter synthetic route and a simpler reaction process.
[0015] 4. The natural product Folicanthine, a dicyclic tryptophan indole alkaloid obtained by the preparation method provided by this invention, can be applied to the research and development of anticancer drugs, especially showing significant inhibitory activity against cancer cells, and has good development prospects. Attached Figure Description
[0016] To more clearly illustrate the technical solutions of the embodiments of the present invention, the accompanying drawings used in the description of the embodiments will be briefly introduced below. Those skilled in the art can obtain other drawings based on these drawings without creative effort.
[0017] Figure 1 This is a schematic diagram of the preparation process of the present invention; Detailed Implementation
[0018] The technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. All other embodiments obtained by those skilled in the art based on the embodiments of the present invention without inventive effort are within the scope of protection of the present invention.
[0019] In order to synthesize the natural product Folicanthine, a dicyclic tryptophan indole alkaloid, in large quantities, and to provide sufficient samples for clinical trials.
[0020] The inventors have provided a method for preparing the natural product Folicanthine, a dicyclic tryptophan indole alkaloid, comprising the following steps: S1. The chiral sulfinimide compound was dissolved in anhydrous methanol, and then reduced by a reducing agent under ice-water bath conditions. After purification, the chiral sulfinamide compound was obtained. Sodium borohydride is the reducing agent in S1.
[0021] S2. The chiral sulfinamide compound was dissolved in anhydrous tetrahydrofuran solvent, and then alkylating agent and sodium hydride were added under ice-water bath and reacted for 10 hours. After purification, methyl-protected chiral sulfinamide compound was obtained. In S2, the alkylating agent is iodomethane.
[0022] S3. The methyl-protected chiral sulfinamide compound was dissolved in anhydrous toluene solvent, and then cuprous iodide and bis(trimethylsilylamine) lithium were added. The mixture was degassed three times under high-purity inert gas protection and then heated for 5 hours. Then, under ice-water bath, an oxidant was added and the reaction was continued for 2 hours. After purification, a dimerized indole compound containing an aryl chiral quaternary carbon center was obtained. In S3, cuprous iodide is used as the catalyst for the reaction, lithium bis(trimethylsilylamine) is used as the base required for the reaction, nitrogen is used as the high-purity inert gas, the heating temperature is 80 degrees Celsius, and iodine is used as the oxidant.
[0023] S4. The dimeric indole compound containing an aryl chiral quaternary carbon center is dissolved in anhydrous methanol solvent, and then dilute hydrochloric acid solution is added and reacted for 5 hours. After reaction treatment, a diamino dimeric indole compound is obtained. Then, it is further reduced with a reducing agent and purified to obtain the natural product Folicanthine, a dimeric cyclotryptamine indole alkaloid.
[0024] In S4, the concentration of dilute hydrochloric acid is 2 mmol / mL, and the reducing agent is diisobutylaluminum hydrogen.
[0025] Furthermore, the purification methods included in S1 to S4 above are as follows: the crude product initially obtained in each step is concentrated, followed by chromatography separation and purification, and finally a compound with high purity is obtained.
[0026] In the process of researching and preparing the natural product Folicanthine, a dicyclic tryptophan indole alkaloid, the inventors also conducted the following specific embodiments: Example 1
[0027] A method for preparing the natural product Folicanthine, a dicyclic tryptophan indole alkaloid (preparation process as follows) Figure 1 (as shown) (1) The synthesis of compound 2 is shown in the following reaction formula:
[0028] The specific implementation method is as follows: 4.9 g of chiral sulfinamide compound 1 was weighed into a 100 mL round-bottom flask, dissolved in 60 mL of anhydrous methanol, and then cooled and stirred for 10 minutes in an ice-water bath at 0 °C. 1.89 g of sodium borohydride solid was slowly added, and the reaction was carried out at 0 °C for 5 hours. Then, the reaction was carried out at room temperature for another 10 hours with stirring. 30 mL of saturated ammonium chloride solution was added for dilution, most of the organic solvent was evaporated to dryness, and the product was extracted three times with ethyl acetate and dried with anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure and subjected to silica gel column chromatography (petroleum ether 60-90 °C: ethyl acetate = 1:2) to obtain 3.71 g of chiral sulfinamide product 2, with a yield of 88%.
[0029] The experimental characterization data for compound 2 are as follows: 1 H NMR (400 MHz, CDCl3) δ 7.85 (d, J =8.0 Hz, 1H), 7.37 (t, J = 7.5 Hz, 1H), 7.22 (dd, J = 14.4, 7.6 Hz, 1H), 7.03(t, J = 7.8 Hz, 1H), 3.58 (t, J = 5.7 Hz, 0.5H), 3.48 (t, J = 5.6 Hz, 0.5H), 3.18 - 3.05 (m, 4H), 3.02 -2.89 (m, 1H), 2.05 -1.87 (m, 2H), 1.85 -1.74 (m, 2H), 1.08 (s, 9H). 13 C NMR (100 MHz, CDCl3) δ 171.91, 171.78, 145.71, 140.05,139.97, 130.00, 129.95, 129.79, 128.96, 128.83, 99.51, 99.46, 55.40, 55.39,44.86, 44.74, 35.80, 35.78, 31.46, 31.36, 25.86, 22.52. HRMS (ESI-TOF) m / z [M+H] + calcd for C 15 H 24 IN2O2S: 423.0598, Found 423.0596. (2) The synthesis of compound 3 is shown in the following reaction formula:
[0030] The specific implementation method is as follows: 4.22 g of chiral amine compound 2 was weighed into a 50 mL single-necked round-bottom flask, dissolved in 50 mL of anhydrous tetrahydrofuran (THF), and then 1.2 g of 60% sodium hydride (NaH) was added under ice-water bath conditions, followed by 0.9 mL of methyl iodide (MeI). After reacting at 0 ºC for 2 hours, the mixture was allowed to return to room temperature and reacted for another 10 hours. Post-treatment: 30 mL of saturated ammonium chloride solution was slowly added, and after stirring for half an hour, most of the organic solvent was evaporated to dryness. Then, the mixture was extracted with ethyl acetate three times, 30 mL each time. The organic phases were combined, dried over anhydrous sodium sulfate, and the filtrate was concentrated under reduced pressure and subjected to silica gel column chromatography (petroleum ether 60-90 ºC: ethyl acetate = 1:1) to obtain 4.14 g of pale yellow liquid chiral sulfinamide compound 3 (95%).
[0031] The experimental data for compound 3 are characterized as follows: 1 H NMR (400 MHz, CDCl3) δ 7.80 (dd, J = 8.0,1.3Hz, 1H), 7.40 -7.34 (m, 1H), 7.23 -7.18 (m, 1H), 7.02 (td, J = 7.8, 1.6Hz,1H), 3.11 (s, 3H), 3.00 -2.80 (m, 1H), 2.51 (s, 1.5H), 2.50 (s, 1.5H), 1.99 -1.75 (m, 4H), 1.03 (s, 4.5H), 1.02 (s, 4.5H). 13 C NMR (100 MHz, CDCl3) δ171.83, 146.00, 145.99, 140.30, 130.17, 129.98, 129.08, 99.75, 99.73, 58.22,54.11, 53.83, 53.54, 35.96, 32.78, 32.59, 31.64, 31.61, 23.79, 23.76, 23.53,23.52. HRMS (ESI-TOF) m / z [M+H] + calcd for C 16 H 26 IN2O2S: 437.0754, Found437.0752. (3) The synthesis of compound 4 is shown in the following reaction formula:
[0032] The specific implementation method is as follows: Cuprous iodide (CuI, 190 mg, 1.0 mmol, 0.1 equiv) and compound 3 (4.36 g, 10.0 mmol) were weighed into a 250 mL double-necked round-bottom flask. The mixture was degassed three times under dry, high-purity nitrogen protection. 100 mL of anhydrous toluene (treated with lithium aluminum hydride under reflux) was added. A solution of bis(trimethylsilylamine)-lithium (1.0 M in THF, 20 mL, 20 mmol, 2.0 equiv) was added with stirring at room temperature. The mixture was then heated in an oil bath at 80 °C for 5 hours, with high-purity nitrogen protection required throughout the reaction. After 5 hours of heating, heating was stopped, the mixture was allowed to return to room temperature, and then cooled to 0 °C using an ice-water bath. 1.27 g of elemental iodine (10 mmol, 1.0 equiv) was slowly added to 5 mL of anhydrous toluene, and the mixture was then reacted at 0 °C for 2 hours. Post-treatment: Add saturated Na2S2O3 solution (10 mL) and saturated ammonium chloride solution (10 mL), stir for 20 minutes, then add 50 mL of water, extract with ethyl acetate (3 × 100 mL), dry with anhydrous sodium sulfate, concentrate the filtrate under reduced pressure, and perform silica gel column chromatography (petroleum ether 60-90℃: ethyl acetate = 2:1 → 1:1) to give 2.49 g of pale yellow liquid compound 4, with a yield of 81%.
[0033] The experimental data for compound 4 are characterized as follows: 1 H NMR (400 MHz, CDCl3) δ 6.98-6.86 (m,2H), 6.80-6.71 (m, 1H), 6.38-6.28 (m, 1H), 3.10-2.90 (m, 4H), 2.60-2.49 (m,3H), 2.49-2.22 (m, 3H), 1.04(s, 4.5H), 1.03(s, 4.5H). 13 C NMR (100 MHz, CDCl3)δ 176.55, 176.47, 143.28, 143.13, 128.76, 128.69, 126.93, 126.78, 122.97,122.79, 121.96, 121.84, 107.87, 107.77, 58.24, 57.91, 54.63, 54.54, 26.93,26.69, 25.77, 23.44, 23.37. HRMS (ESI-TOF) m / z [M+H] + calcd for C 32 H47 N4O4S2:615.3033, Found 615.3035. (4) The synthesis of Folicanthine, a natural product of dicyclic tryptamine indole alkaloid of compound 5, is shown in the following reaction formula:
[0034] The specific implementation method is as follows: 614 mg of compound 4 (1.0 mmol) was weighed and dissolved in 5 mL of anhydrous methanol, then 1.5 mL of dilute hydrochloric acid (4N, 6.0 mmol, 6.0 equiv.) was added, and the reaction was carried out at room temperature for 3 hours. Post-treatment: saturated sodium bicarbonate solution was added until the pH was >7, diluted with 5 mL of water, and most of the organic solvent was evaporated. Then, the mixture was extracted with dichloromethane (3 × 15 mL), washed with brine, and the organic phases were combined, dried over anhydrous sodium sulfate, concentrated under reduced pressure, and evaporated to dryness to obtain the crude product. The crude product was then dissolved in 15 mL of anhydrous tetrahydrofuran solution, degassed three times under nitrogen protection, and the reaction was carried out in an ice-water bath. 6 mL of diisobutylaluminum hydride solution (1 M in THF, 6.0 mmol, 6.0 equiv.) was slowly added, and the reaction was continued for 1 hour, followed by 2 hours at room temperature. The reaction was then carried out in an oil bath for 12 hours. After the reaction was complete, 5 mL of saturated potassium sodium tartrate solution was added, and the mixture was extracted with ethyl acetate (3 × 15 mL), dried over anhydrous sodium sulfate, and the filtrate was concentrated under reduced pressure and subjected to silica gel column chromatography (petroleum ether 60-90℃: ethyl acetate = 2:1 → 1:1) to give 243 mg of the pale yellow liquid compound, the natural product folicanthine, a 5-dicyclic tryptamine indole alkaloid, in a yield of 65%.
[0035] The experimental data for compound 5 are characterized as follows: 1 H-NMR (300 MHz, CDCl3) δ 7.03-6.87 ( m , 2H), 6.50 ( t , J = 7.5 Hz, 1H), 6.26 ( d , J = 7.5 Hz, 1H), 4.39 ( brs , 1H), 3.00 ( s ,3H), 2.71-2.57 ( m , 1H), 2.51-2.33 ( m, 2H), 2.41 ( s, 3H), 2.04-1.91 (m, 1H). 13 C-NMR (75 MHz, CDCl3), δ (ppm): 152.94, 132.81, 128.20, 123.73, 116.76, 105.95,91.90, 62.68, 52.70, 37.93, 35.57, 35.30. HRMS (ESI-TOF) m / z [M+H] + calcd forC 24 H 31 N4: 375.2543, Found 375.2541. As can be seen from the above embodiments, the preparation method provided by the present invention has a high product yield, a short synthetic route, a relatively simple reaction operation process, and good atom economy.
[0036] It will be apparent to those skilled in the art that the present invention is not limited to the details of the exemplary embodiments described above, and that the invention can be implemented in other specific forms without departing from its spirit or essential characteristics. Therefore, the embodiments should be considered in all respects as exemplary and non-limiting, and the scope of the invention is defined by the appended claims rather than the foregoing description. Thus, all variations falling within the meaning and scope of equivalents of the claims are intended to be included within the present invention. No reference numerals in the claims should be construed as limiting the scope of the claims.
[0037] Furthermore, it should be understood that although this specification describes embodiments, not every embodiment contains only one independent technical solution. This narrative style is merely for clarity. Those skilled in the art should consider the specification as a whole, and the technical solutions in each embodiment can also be appropriately combined to form other embodiments that can be understood by those skilled in the art.
Claims
1. A method for preparing the natural product Folicanthine, a dicyclic tryptophan indole alkaloid, characterized in that, Includes the following steps: S1. The chiral sulfinylimide compound is dissolved in anhydrous methanol, then reduced by a reducing agent under ice-water bath conditions, and purified to obtain the chiral sulfinamide compound; wherein, the molecular structural formula 1 of the chiral sulfinylimide compound is: ; The molecular structural formula 2 of the chiral sulfinamide compound is: ; S2. The chiral sulfinamide compound was dissolved in anhydrous tetrahydrofuran solvent, and then reacted with an alkylating agent and sodium hydride in an ice-water bath for 10 hours. After purification, a methyl-protected chiral sulfinamide compound was obtained; wherein, the molecular structural formula 3 of the chiral sulfinamide compound is: ; S3. The methyl-protected chiral sulfinamide compound was dissolved in anhydrous toluene, and then cuprous iodide and lithium bis(trimethylsilylamine) were added. The mixture was degassed three times under high-purity inert gas protection, and then heated for 5 hours. Then, an oxidant was added in an ice-water bath and the reaction continued for 2 hours. After purification, a dimerized indole compound containing an aryl chiral quaternary carbon center was obtained. The molecular structure of the dimerized indole compound is shown in formula 4. ; S4. The dimerized indole compound containing an aryl chiral quaternary carbon center is dissolved in anhydrous methanol, and then dilute hydrochloric acid solution is added to react for 5 hours. After reaction treatment, a diamino dimerized indole compound is obtained. Then, it is further reduced with a reducing agent and purified to obtain the natural product Folicanthine, a dimerized cyclotryptamine indole alkaloid. The molecular structural formula of the dimerized indole compound is: 。 2. The method for preparing the natural product Folicanthine, a dicyclic tryptophan indole alkaloid, according to claim 1, is characterized in that, Sodium borohydride is the reducing agent in S1.
3. The method for preparing the natural product Folicanthine, a dicyclic tryptophan indole alkaloid, according to claim 1, is characterized in that... The alkylating agent in S2 is iodomethane.
4. The method for preparing the natural product Folicanthine, a dicyclic tryptophan indole alkaloid, according to claim 1, is characterized in that... In S3, cuprous iodide is used as the catalyst for the reaction, lithium bis(trimethylsilylamine) is used as the base required for the reaction, nitrogen is used as the high-purity inert gas, the heating temperature is 80 degrees Celsius, and iodine is used as the oxidant.
5. The method for preparing the natural product Folicanthine, a dicyclic tryptophan indole alkaloid, according to claim 1, is characterized in that... The concentration of dilute hydrochloric acid used in S4 is 2 mmol / mL, and the reducing agent is diisobutylaluminum hydrogen.
6. The method for preparing the natural product Folicanthine, a dicyclic tryptophan indole alkaloid, according to claim 1, is characterized in that, The purification methods included in S1~S4 are as follows: the crude product initially obtained in each step is concentrated, followed by chromatography separation and purification, and finally a compound with high purity is obtained.
